Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process

  Calgary, AB – TheNewswire - December 18, 2025 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following initial bi-weekly default status report update:Management Cease Trade Order (“MCTO”)Further to the Company’s prior news releases (dated November 25, 2025), the Company is providing this bi-weekly default status report (the “Default Status Report”) in accordance with National Policy ...